GIUSEPPE GALLI-BIBIENA'S ARCHITETTURE E PROSPETTIVESAXON A. H.MASKE UND KOTHURN. 1969, Vol 15, Num 2, pp 105-118Article

ANTIGEN-INDUCED SUPPRESSION OF HUMAN IN VITRO POKEWEED MITOGEN-STIMULATED ANTIBODY PRODUCTIONSTEVENS RH; SAXON A.1980; CELL. IMMUNOL.; ISSN 0008-8749; USA; DA. 1980; VOL. 55; NO 1; PP. 85-93; BIBL. 32 REF.Article

ANTI-HUMAN HELPER T-LYMPHOCYTE ANTISERUM: GENERATION AND FUNCTIONAL CHARACTERIZATION.STEVENS RH; SAXON A.1978; CLIN. IMMUNOL. IMMUNOPATHOL.; USA; DA. 1978; VOL. 10; NO 4; PP. 438-445; BIBL. 27 REF.Article

What impact will the immune tolerance network have on the future treatment of allergic diseases?SAXON, A.Clinical and experimental allergy (Print). 2004, Vol 34, Num 11, pp 1657-1659, issn 0954-7894, 3 p.Article

Going redSAXON, A.Fire prevention (London. 1971). 1996, Num 295, pp 18-19, issn 0309-6866Article

LYMPHOID SUBPOPULATION CHANGES IN REGIONAL LYMPH NODES IN SQUAMOUS HEAD AND NECK CANCER.SAXON A; PORTIS J.1977; CANCER RES.; U.S.A.; DA. 1977; VOL. 37; NO 4; PP. 1154-1158; BIBL. 33 REF.Article

DIFFERENTIAL SYNTHESIS OF IGM AND IGG ANTI-TETANUS TOXOID ANTIBODY IN VITRO FOLLOWING IN VIVO BOOSTER IMMUNIZATION OF HUMANSSTEVENS RH; SAXON A.1979; CELL. IMMUNOL.; USA; DA. 1979; VOL. 45; NO 1; PP. 142-150; BIBL. 33 REF.Article

STIMULATION AND REGULATION OF HUMAN IGE PRODUCTION IN VITRO USING PERIPHERAL BLOOD LYMPHOCYTESSAXON A; STEVENS RH.1979; CLIN. IMMUNOL. IMMUNOPATHOL.; USA; DA. 1979; VOL. 14; NO 4; PP. 474-488; BIBL. 32 REF.Article

IMMUNOREGULATION IN HUMANS: CONTROL OF ANTITETANUS TOXOID ANTIBODY PRODUCTION AFTER BOOSTER IMMUNIZATIONSTEVENS RH; SAXON A.1978; J. CLIN. INVEST.; USA; DA. 1978; VOL. 62; NO 6; PP. 1154-1160; BIBL. 36 REF.Article

PRESERVATION OF IN VITRO BIOLOGICAL FUNCTIONS IN REGIONAL LYMPH NODE LYMPHOCYTES IN SQUAMOUS HEAD AND NECK CANCER.SAXON A; PORTARO J.1977; CANCER RES.; U.S.A.; DA. 1977; VOL. 37; NO 4; PP. 1159-1164; BIBL. 19 REF.Article

SUPPRESSION OF IMMUNOGLOBULIN PRODUCTION IN NORMAL HUMAN BLOOD: CHARACTERIZATION OF THE CELLS RESPONSIBLE AND MEDIATION BY A SOLUBLE T LYMPHOCYTE-DERIVED FACTOR.SAXON A; STEVENS RH.1978; CLIN. IMMUNOL. IMMUNOPATHOL.; USA; DA. 1978; VOL. 10; NO 4; PP. 427-437; BIBL. 29 REF.Article

HUMAN T LYMPHOCYTE-DERIVED HELPER FACTOR (HHF) = CELLULAR AND PHYSICAL CHARACTERIZATIONSAXON A; STEVENS RH.1979; CLIN. IMMUNOL. IMMUNOPATHOL.; USA; DA. 1979; VOL. 12; NO 1; PP. 82-93; BIBL. 23 REF.Article

REDUCED IN VITRO PRODUCTION OF ANTI-TETANUS TOXOID ANTIBODY AFTER REPEATED IN VIVO IMMUNIZATION WITH TETANUS TOXOIDSTEVENS RH; SAXON A.1979; J. IMMUNOL.; USA; DA. 1979; VOL. 122; NO 2; PP. 592-598; BIBL. 40 REF.Article

IN VITRO DEPRESSION OF HUMAN LYMPHOCYTE MITOGEN RESPONSE (PHYTOHAEMAGGLUTININ) BY ASBESTOS FIBRESBARBERS RG; SHIH WWH; SAXON A et al.1982; CLINICAL AND EXPERIMENTAL IMMUNOLOGY; ISSN 0009-9104; GBR; DA. 1982; VOL. 48; NO 3; PP. 602-610; BIBL. 20 REF.Article

PROFILE OF MULTIPLE LYMPHOCYTE FUNCTIONAL DEFECTS IN ACQUIRED HYPOGAMMAGLOBULINEMIA, DERIVED FROM IN VITRO CELL RECOMBINATION ANALYSISASHMAN RF; SAXON A; STEVENS RH et al.1980; J. ALLERGY CLIN. IMMUNOL.; USA; DA. 1980; VOL. 65; NO 4; PP. 242-256; BIBL. 26 REF.Article

BILATERAL HYPERNEPHROMA WITH SOLITARY PANCREATIC METASTASISSAXON A; GOTTESMAN J; DOOLAS A et al.1980; J. SURG. ONCOL.; USA; DA. 1980; VOL. 13; NO 4; PP. 317-322; BIBL. 23 REF.Article

LECTIN-DEPENDENT CELLULAR CYTOTOXICITY IN MAN.BONAVIDA B; ROBINS A; SAXON A et al.1977; TRANSPLANTATION; U.S.A.; DA. 1977; VOL. 23; NO 3; PP. 261-270; BIBL. 34 REF.Article

ANGIOIMMUNOBLASTIC LYMPHADENOPATHY WITH DYSPROTEINEMIA. A PATHOGENETIC LINK BETWEEN PHYSIOLOGIC LYMPHOID PROLIFERATION AND MALIGNANT LYMPHOMABLUMING AZ; COHEN HG; SAXON A et al.1979; AMER. J. MED.; USA; DA. 1979; VOL. 67; NO 3; PP. 421-428; BIBL. 50 REF.Article

SINGLE STEP SEPARATION OF HUMAN T AND B CELLS USING AET TREATED SRBC ROSETTES.SAXON A; FELDHAUS J; ROBINS RA et al.1976; J. IMMUNOL. METHODS; NETHERL.; DA. 1976; VOL. 12; NO 3-4; PP. 285-288; BIBL. 9 REF.Article

INABILITY OF PATIENTS WITH COMMON VARIABLE HYPOGAMMAGLOBULINEMIA TO GENERATE LYMPHOBLASTOID B CELLS FOLLOWING BOOSTER IMMUNIZATIONSTEVENS RH; TAMAROFF M; SAXON A et al.1980; CLIN. IMMUNOL. IMMUNOPATHOL.; USA; DA. 1980; VOL. 16; NO 3; PP. 336-343; BIBL. 21 REF.Article

ISOTYPE-SPECIFIC HUMAN B LYMPHOCYTES THAT PRODUCE IMMUNOGLOBULIN E IN VITRO WHEN STIMULATED BY POKEWEED MITOGENSAXON A; KAPLAN M; STEVENS RH et al.1980; J. ALLERGY CLIN. IMMUNOL.; ISSN 0091-6749; USA; DA. 1980; VOL. 66; NO 3; PP. 233-241; BIBL. 33 REF.Article

THE PRODUCTION OF A SOLUBLE HUMAN T-LYMPHOCYTE DERIVED FACTOR WHICH SUBSTITUTES FOR HELPER T LYMPHOCYTES IN THE IN VITRO PRODUCTION OF IMMUNOGLOBULINSTEVENS RH; THIELE CJ; SAXON A et al.1979; IMMUNOLOGY; GBR; DA. 1979; VOL. 36; NO 3; PP. 407-413; BIBL. 18 REF.Article

MEMBRANE LIPID CHANGES ASSOCIATED WITH MALIGNANT TRANSFORMATION AND NORMAL MATURATION OF HUMAN LYMPHOCYTES.PRATT HPM; SAXON A; GRAHAM ML et al.1978; LEUKEMIA RES.; GBR; DA. 1978; VOL. 2; NO 1; PP. 1-10; BIBL. 50 REF.Article

RHINOPHARYNGOSCOPY FOR THE EVALUATION OF ALLERGIC-IMMUNOLOGIC DISORDERSROHR A; HASSNER A; SAXON A et al.1983; ANNALS OF ALLERGY; ISSN 0003-4738; USA; DA. 1983; VOL. 50; NO 6; PP. 380-384; BIBL. 3 REF.Article

SUBPOPULATIONS OF CIRCULATING B CELLS AND REGULATORY T CELLS INVOLVED IN IN VITRO IMMUNOGLOBULIN E PRODUCTION IN ATOPIC PATIENTS WITH ELEVATED SERUM IMMUNOGLOBULIN ESAXON A; MORROW C; STEVENS RH et al.1980; J. CLIN. INVEST; USA; DA. 1980; VOL. 65; NO 6; PP. 1457-1468; BIBL. 39 REF.Article